Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion

Neuropathology

Volumn 34, Issue 1, 2014, Pages 32-38

  Hewer, Ekkehard ^a   Beck, Jürgen ^b   Vassella, Erik ^a   Vajtai, Istvan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Brain stem; Cerebellum; Differential diagnosis; Loss of heterozygosity; Oligodendroglioma

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN STEM; CASE REPORT; CEREBELLUM; CHROMOSOME DELETION; CHROMOSOME DELETION 1P/19Q; DYSPHAGIA; FEMALE; FEVER; GIANT CELL; HUMAN; HUMAN TISSUE; HYPESTHESIA; MEDULLA OBLONGATA; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; STEREOTACTIC BIOPSY;

BRAIN STEM; CEREBELLUM; DIFFERENTIAL DIAGNOSIS; LOSS OF HETEROZYGOSITY; OLIGODENDROGLIOMA;

BRAIN STEM NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; MIDDLE AGED; OLIGODENDROGLIOMA;

EID: 84892791398     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12043     Document Type: Article

References (43)

1. Aldape K, Burger PC, Perry A. Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma. Arch Pathol Lab Med 2007; 131: 242-251.
2. Mohindra S, Savardekar A, Bal A. Pediatric brainstem oligodendroglioma. J Neurosci Rural Pract 2012; 3: 52-54.
3. Mittelbronn M, Wolff M, Bültmann E etal. Disseminating anaplastic brainstem oligodendroglioma associated with allelic loss in the tumor suppressor candidate region D19S246 of chromosome 19 mimicking an inflammatory central nervous system disease in a 9-year-old boy. Hum Pathol 2005; 36: 854-857.
4. Chitkara N, Chanda R, Thakur AK, Chanda S, Sharma NK. Posterior fossa oligodendroglioma. Indian J Pediatr 2002; 69: 1099-1100.
5. Nam DH, Cho BK, Kim YM, Chi JG, Wang KC. Intramedullary anaplastic oligodendroglioma in a child. Childs Nerv Syst 1998; 14: 127-130.
6. Alvarez JA, Cohen ML, Hlavin ML. Primary intrinsic brainstem oligodendroglioma in an adult. Case report and review of the literature. J Neurosurg 1996; 85: 1165-1169.
7. de Chadarevian JP, Legido A, Halligan GE etal. Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature. J Child Neurol 2011; 27: 511-520.
8. Nadkarni TD, Menon RK, Desai KI, Goel AH. Cerebellar oligodendroglioma in a young adult. J Clin Neurosci 2005; 12: 837-838.
9. Shah S, Schelper RL, Krishnamurthy S, Chang HT. An 11-year-old boy with an incidental mass in the left lateral cerebellum. Neuropathology 2007; 27: 95-97.
10. El Ouni F, Gaha M, Moulahi H, Daadoucha A, Krifa H, Tlili K. Infratentorial oligodendroglioma in a child: case report and review of the literature. Turk Neurosurg 2010; 22: 461-464.
11. Lee IH, Kim ST, Suh Y-L etal. Infratentorial oligodendrogliomas: imaging findings in six patients. Acta Radiol 2010; 51: 213-217.
12. Koeppen AH, Cassidy RJ. Oligodendroglioma of the medulla oblongata in a neonate. Arch Neurol 1981; 38: 520-523.
13. Packer RJ, Sutton LN, Rorke LB etal. Oligodendroglioma of the posterior fossa in childhood. Cancer 1985; 56: 195-199.
14. Burger PC. What is an oligodendroglioma? Brain Pathol 2002; 12: 257-259.
15. Gru AA, Fulling K, Perry A. A 39 year-old man with a cerebellar mass and pancytopenia. Brain Pathol 2012; 22: 251-254.
16. Furtado SV, Venkatesh PK, Ghosal N, Murthy GK, Hegde AS. Clinical and radiological features of pediatric cerebellar anaplastic oligodendrogliomas. Indian J Pediatr 2011; 78: 880-883.
17. Utsuki S, Oka H, Kijima C, Yasui Y, Fujii K, Kawano N. Pilocytic astrocytoma with abundant oligodendroglioma-like component. Brain Tumor Pathol 2012; 29: 103-106.
18. Katoh M, Satoh T, Nishiya M etal. Clear cell ependymoma of the fourth ventricle. Neuropathology 2004; 24: 330-335.
19. Kim JH, Cho BK, Kim IO, Park SH. Clear-cell ependymoma of the cerebellum: a case report. Ultrastruct Pathol 2007; 31: 241-247.
20. Jain D, Roy S, Chopra S. Atypical central neurocytoma of fourth ventricle with hemorrhagic complication during surgery in a child. Clin Neurol Neurosurg 2012; 114: 182-184.
21. Makhdoomi R, Malik NK, Wani A, Bhat S, Baba K. Extraventricular neurocytoma of the vermis in a child. J Clin Neurosci 2010; 17: 1469-1471.
22. Vajtai I, Arnold M, Kappeler A etal. Rosette-forming glioneuronal tumor of the fourth ventricle: report of two cases with a differential diagnostic overview. Pathol Res Pract 2007; 203: 613-619.
23. George DH, Scheithauer BW. Central liponeurocytoma. Am J Surg Pathol 2001; 25: 1551-1555.
24. Campbell BA, Horsman DE, Maguire J etal. Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status? J Neurooncol 2008; 89: 37-45.
25. Vajtai I, Vassella E, Hewer E, Kappeler A, Reinert MM. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors. Pathol Res Pract 2012; 208: 750-755.
26. Vassella E, Vajtai I, Bandi N, Arnold M, Kocher V, Mariani L. Primer extension based quantitative polymerase chain reaction reveals consistent differences in the methylation status of the MGMT promoter in diffusely infiltrating gliomas (WHO grade II-IV) of adults. J Neurooncol 2010; 104: 293-303.
27. Fouladi M, Helton K, Dalton J etal. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 2003; 98: 2232-2244.
28. Ellezam B, Theeler BJ, Luthra R, Adesina AM, Aldape KD, Gilbert MR. Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor. Acta Neuropathol 2011; 123: 285-287.
29. Korshunov A, Meyer J, Capper D etal. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 2009; 118: 401-405.
30. Ligon KL, Alberta JA, Kho AT etal. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004; 63: 499-509.
31. Mrak RE. The Big Eye in the 21st century: the role of electron microscopy in modern diagnostic neuropathology. J Neuropathol Exp Neurol 2002; 61: 1027-1039.
32. Capper D, Reuss D, Schittenhelm J etal. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 2010; 121: 241-252.
33. Capper D, Weissert S, Balss J etal. Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 2010; 20: 245-254.
34. Vajtai I, Arnold M, Vassella E. Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q. Acta Neuropathol 2005; 110: 520-522.
35. Jouvet A, Lellouch-Tubiana A, Boddaert N, Zerah M, Champier J, Fevre-Montange M. Fourth ventricle neurocytoma with lipomatous and ependymal differentiation. Acta Neuropathol 2005; 109: 346-351.
36. Rodriguez FJ, Perry A, Rosenblum MK etal. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012; 124: 627-641.
37. Agamanolis DP, Katsetos CD, Klonk CJ etal. An unusual form of superficially disseminated glioma in children: report of 3 cases. J Child Neurol 2012; 27: 727-733.
38. Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 2005; 109: 387-392.
39. McDonald JM, See SJ, Tremont IW etal. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer 2005; 104: 1468-1477.
40. Perry A, Burton SS, Fuller GN etal. Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall. Acta Neuropathol 2010; 120: 237-252.
41. Zülch KJ. On the definition of the polymorphous oligodendroglioma. Acta Neurochir (Wien) 1964; 11 (Suppl 10): S166-172.
42. Kros JM, Lie ST, Stefanko SZ. Familial occurrence of polymorphous oligodendroglioma. Neurosurgery 1994; 34: 732-736.
43. Hewer E, Beck J, Murek M, Vassella E, Vajtai I. Polymorphous oligodendroglioma of Zülch revisited - a genetically diverse group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiaton. Clin Neuropathol 2012; 31: P017. (Abstract).